CA 15-3 prognostic biomarker in SARS-CoV-2 pneumonia

Autor: José Antonio Ros-Lucas, Domingo Andrés Pascual-Figal, José Antonio Noguera-Velasco, Álvaro Hernández-Vicente, Iria Cebreiros-López, María Arnaldos-Carrillo, Isabel M. Martínez-Ardil, Elisa García-Vázquez, Mario Aparicio-Vicente, Elena Solana-Martínez, Sheyla Yolany Ruiz-Martínez, Laura Fernández-Mula, Rubén Andujar-Espinosa, Beatriz Fernández-Suarez, Maria Dolores Sánchez-Caro, Carlos Peñalver-Mellado, Francisco José Ruiz-López

Publikováno v: Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)

Abstract The severity of lung involvement is the main prognostic factor in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Carbohydrate antigen 15-3 (CA 15-3), a marker of lung damage and fibrosis, could help predict the progn

Externí odkaz: https://doaj.org/article/5c22cbfac9b142eea1d3c7dd7cf7d2dd

CA 15-3 prognostic biomarker in SARS-CoV-2 pneumonia

Autor: José Antonio Ros-Lucas, Domingo Andrés Pascual-Figal, José Antonio Noguera-Velasco, Álvaro Hernández-Vicente, Iria Cebreiros-López, María Arnaldos-Carrillo, Isabel M. Martínez-Ardil, Elisa García-Vázquez, Mario Aparicio-Vicente, Elena Solana-Martínez, Sheyla Yolany Ruiz-Martínez, Laura Fernández-Mula, Rubén Andujar-Espinosa, Beatriz Fernández-Suarez, Maria Dolores Sánchez-Caro, Carlos Peñalver-Mellado, Francisco José Ruiz-López

Publikováno v: Scientific reports. 12(1)

The severity of lung involvement is the main prognostic factor in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Carbohydrate antigen 15-3 (CA 15-3), a marker of lung damage and fibrosis, could help predict the prognosis of S

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7bc2bbca4a7b18254e09ed93771b28a
https://pubmed.ncbi.nlm.nih.gov/35469047

Next step in molecular genetics of hereditary breast/ovarian cancer: Multigene panel testing in clinical actionably genes and prioritization algorithms in the study of variants of uncertain significance

Autor: Verónica Castillo-Guardiola, Laura Rosado-Jiménez, María Desamparados Sarabia-Meseguer, Miguel Marín-Vera, José Antonio Macías-Cerrolaza, Rosario García-Hernández, Marta Zafra-Poves, Pilar Sánchez-Henarejos, María Ángeles Moreno-Locubiche, Encarnación Cuevas-Tortosa, María Arnaldos-Carrillo, Francisco Ayala de la Peña, José Luis Alonso-Romero, José Antonio Noguera-Velasco, Francisco Ruiz-Espejo

Publikováno v: European journal of medical genetics. 65(4)

BRCA1 and BRCA2 are the two main genes causing hereditary breast and ovarian cancer (HBOC). However, thanks to the development of Next Generation Sequencing (NGS), other genes linked to this syndrome (CHEK2, BRIP1, ATM and PALB2 among others) can be

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7be3e6b354c07949a73a5973ed157e0d
https://pubmed.ncbi.nlm.nih.gov/35245693

Characteristics and laboratory findings on admission to the emergency department among 2873 hospitalized patients with COVID-19: the impact of adjusted laboratory tests in multicenter studies. A multicenter study in Spain (BIOCOVID-Spain study)

Autor: Laura Sahuquillo Frías, Mercedes González Morales, Alfonso-L Blazquez-Manzanera, Matilde Cháfer Rudilla, Yolanda Pastor Murcia, María C Baamonde Calzada, María L López Yepes, Luis García de Guadiana-Romualdo, Amparo Galán Ortega, Juan Adell Ruiz de León, Jose I Gutiérrez Revilla, María Gloria García Arévalo, Cristina Acevedo Alcaraz, Ruth González Tamayo, Amaia Fernández Uriarte, Álex Larruzea, Luis Vicente Gutiérrez, Josep Miquel Bauça, Álvaro Blasco Barbero, Marina Vera, Jose M Álamo, Paloma Salas Gómez-Pablos, Silvia Sánchez Fdez-Pacheco, Luis Sáenz, Olaia Rodríguez-Fraga, Jorge Férriz Vivancos, Cristina Ruiz Iruela, María-Carmen Lorenzo-Lozano, Patricia Esteban Torrella, Laura Altimira Queral, Daniel Morell-García, Sara García Muñoz, Eloísa Urrechaga, Natalia Sancho-Rodríguez, Juan A Vílchez, Patricia de la Hera Cagigal, Alfonso Pérez Martínez, José Pedregosa Díaz, María Arnaldos Carrillo, Laura Jiménez Añón, Jose Manuel Egea-Caparrós, María Núñez Gárate, Vicente Aguadero, Vicente Ferrer Díaz de Brito Fernández, María C Zamorano Andrés, Ana María Lourdes Padilla Jiménez, Iria Cebreiros López, Elisa Nuez-Zaragoza, Irene Gutiérrez Garcia, Clara Esparza Del Valle, Martí Vila Pérez, Magdalena Canalda Campás, Cristian Morales-Indiano, María A Juncos Tobarra, Alicia Ruiz Ripa, Ana M Hernando Holgado, Isabel Vírseda Chamorro, Aurelio Pons Castillo, María José Alcaide Martín

Publikováno v: SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
SCAND J CLIN LAB INV
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Scandinavian Journal of Clinical and Laboratory Investigation
article-version (VoR) Version of Record
r-FISABIO. Repositorio Institucional de Producción Científica

Identification of predictors for severe disease progression is key for risk stratification in COVID-19 patients. We aimed to describe the main characteristics and identify the early predictors for severe outcomes among hospitalized patients with COVI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa0a2bbadb25a1bcc508b3259aa69a98
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2155